Prellis Biologics
Berkeley
About Prellis Biologics
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics' technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $79.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2025)
- Website: prellisbio.com
- Phone: 510-200-7698
Industries & Categories
3D Printing, Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/prellis-biologics-42360 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.